Cytokine genotype and phenotype effects on lung function decline in firefighters

Journal of Occupational and Environmental Medicine

Volumn 49, Issue 3, 2007, Pages 282-288

  Josyula, Arun B ^a   Kurzius Spencer, Margaret ^a   Littau, Sally R ^a   Yucesoy, Berran ^b   Fleming, James ^c   Burgess, Jefferey L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c Fire Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL COUNT; CONTROLLED STUDY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRE FIGHTER; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OCCUPATIONAL LUNG DISEASE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM ANALYSIS; SPUTUM LEVEL;

ADULT; CYTOKINES; FEMALE; FIRES; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; PHENOTYPE; QUESTIONNAIRES; REGRESSION ANALYSIS; SPIROMETRY; SPUTUM;

EID: 33947172557     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3180322584     Document Type: Article

References (44)

1. Dockery DW, Speizer FE, Ferris BG Jr, et al. Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. Am Rev Respir Dis. 1988;137:286-292.
2. Burgess JL, Fierro MA, Lantz RC, et al. Longitudinal decline in lung function: evaluation of interleukin-10 genetic polymorphisms in firefighters. J Occup Environ Med. 2004;46:1013-1022.
3. Burrows B, Lebowitz MD, Camilli AE, et al. Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. Am Rev Respir Dis. 1986;133:974-980.
4. Celli BR, Halbert RJ, Nordyke RJ, et al. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med 2005;118:1364-1372.
5. Habib MP, Klink ME, Knudson DE, et al. Physiologic characteristics of subjects exhibiting accelerated deterioration of ventilatory function. Am Rev Respir Dis. 1987;136:638-645.
6. Sandford AJ, Chagani T, Weir TD, et al. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med. 2001;163:469-473.
7. Joos LL, McIntyre J, Ruan JE, et al. Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax. 2001;56:863-866.
8. Burgess, JL, Witten ML, Nanson CJ, et al. Serum pneumoproteins: a cross-sectional comparison of firefighters and police. Am J Ind Med. 2003;44:246-253.
9. Huang SL, Su CH, Chang SC. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med. 1997;156:1436-1439.
10. Sakao SK, Tatsumi H, Igari R, et al. Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. Chest. 2002;122:416-420.
11. Hernandez A, Omini C, Daffonchio L. Interleukin-1 beta: a possible mediator of lung inflammation and airway hyperreactivity. Pharmacol Res. 1991;24:385-393.
12. Smith CA, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 1997;350:630-633.
13. Sousa AR, Lane SJ, Nakhosteen JA, et al. Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med. 1996;154:1061-1066.
14. Yamamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest. 1997;112:505-510.
15. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153:530-534.
16. Yucesoy BV, Vallyathan DP, Landsittel DS, et al. Polymorphisms of the IL-1 gene complex in coal miners with silicosis. Am J Ind Med. 2001;39:286-291.
17. Standardization of spirometry - 1987 update. Official statement of American Thoracic Society. Respir Care. 1987;32:1039-1060.
18. Driscoll KE, Carter JM, Hassenbein DG, et al. Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect. 1997;105(Suppl 5):1159-1164.
19. Vanhee D, Gosset P, Boitelle A, et al. Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. Eur Respir J. 1995;8:834-842.
20. de Waal Malefyt R, Moore KW. Interleukin-10. In: Thomson AW, editor. The Cytokine Handbook. 3rd ed. San Diego: Academic Press; 1998. pp. 333-364.
21. Karjalainen J, Joki-Erkkila VP, Hulkkonen J, et al. The IL1A genotype is associated with nasal polyposis in asthmatic adults. Allergy. 2003;58:393-396.
22. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 1998;47:195-198.
23. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol. 1992;4:314-320.
24. Chang YH, Huang CN, Wu CY, et al. Shiau. Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum Immunol. 2005;66:1258-1263.
25. Ma, SL, Tang NL, Lam LC, et al. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiol Aging. 2005;26:1005-1010.
26. Kadota JY, Matsubara Y, Ishimatsu M, et al. Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB). Clin Exp Immunol. 1996;103:461-466.
27. Donnelly SC, Strieter RM, Reid PT, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 1996;125:191-196.
28. Yucesoy B, Vallyathan V, Landsittel DP, et al. Association of tumor necrosis factor-alpha and interleukin-1 gene polymorphisms with silicosis. Toxicol Appl Pharmacol. 2001;172:75-82.
29. Hernandez-Guerrero C, Monzon-Bordonaba F, Jimenez-Zamudio L, et al. In-vitro secretion of proinflammatory cytokines by human aminochorion carrying hyper-responsive gene polymorphisms of tumour necrosis factor-alpha and interleukin-1beta. Mol Hum Reprod. 2003;9:625-629.
30. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol. 1998;28:2598-2602.
31. Rupp J, Kothe H, Mueller A, et al. Imbalanced secretion of IL-1beta and IL-1RA in Chlamydia pneumoniaeinfected mononuclear cells from COPD patients. Eur Respir J. 2003;22:274-279.
32. Soler N, Ewig S, Torres A, et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999;14:1015-1022.
33. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax. 2000;55:1023-1027.
34. Schulz C, Kratzel K, Wolf K, et al. Activation of bronchial epithelial cells in smokers without airway obstruction and patients with COPD. Chest. 2004;125:1706-1713.
35. Di Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med. 1998;158:1277-1285.
36. Barnes PJ, Chowdhury B, Kharitonov SA, et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174:6-14.
37. Goodman RM, Yergin BM, Landa JF, et al. Relationship of smoking history and pulmonary function tests to tracheal mucous velocity in nonsmokers, young smokers, ex-smokers, and patients with chronic bronchitis. Am Rev Respir Dis. 1978;117:205-214.
38. Ryan SF, Vincent TN, Mitchell RS, Filley GF, Dart G. Ductectasia; an asymptomatic pulmonary change related to age. Med Thorac. 1965;22:181-187.
39. Pierce JA, Hocott JB. Studies on the collagen and elastin content of the human lung. J Clin Invest. 1960;39:8-14.
40. Knudson RJ, Clark DF, Kennedy TC, et al. Effect of aging alone on mechanical properties of the normal adult human lung. J Appl Physiol. 1977;43:1054-1062.
41. Burgess JL, Nanson CJ, Bolstad-Johnson DM, et al. Adverse respiratory effects following overhaul in firefighters. J Occup Environ Med. 2001;43:467- 473.
42. Peters JM, Theriault GP, Fine LJ, et al. Chronic effect of fire fighting on pulmonary function. N Engl J Med. 1974;291:1320-1322.
43. Sparrow D, Bosse R, Rosner B, et al. The effect of occupational exposure on pulmonary function: a longitudinal evaluation of fire fighters and nonfire fighters. Am Rev Respir Dis. 1982;125:319-322.
44. Horsfield K, Guyatt AR, Cooper FM, et al. Lung function in West Sussex firemen: a four year study. Br J Ind Med. 1988;45:116-121.